Yüklüyor......
Response of Degarelix treatment in human prostate cancer monitored by HR-MAS (1)H NMR spectroscopy
INTRODUCTION: The androgen receptor (AR) is the master regulator of prostate cancer cell metabolism. Degarelix is a novel gonadotrophin-releasing hormone blocker, used to decrease serum androgen levels in order to treat advanced human prostate cancer. Little is known of the rapid metabolic response...
Kaydedildi:
| Yayımlandı: | Metabolomics |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927592/ https://ncbi.nlm.nih.gov/pubmed/27429605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1055-0 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|